TRPC6 in simulated microgravity of intervertebral disc cells

Eur Spine J. 2018 Oct;27(10):2621-2630. doi: 10.1007/s00586-018-5688-8. Epub 2018 Jul 2.

Abstract

Purpose: Prolonged bed rest and microgravity in space cause intervertebral disc (IVD) degeneration. However, the underlying molecular mechanisms are not completely understood. Transient receptor potential canonical (TRPC) channels are implicated in mechanosensing of several tissues, but are poorly explored in IVDs.

Methods: Primary human IVD cells from surgical biopsies composed of both annulus fibrosus and nucleus pulposus (passage 1-2) were exposed to simulated microgravity and to the TRPC channel inhibitor SKF-96365 (SKF) for up to 5 days. Proliferative capacity, cell cycle distribution, senescence and TRPC channel expression were analyzed.

Results: Both simulated microgravity and TRPC channel antagonism reduced the proliferative capacity of IVD cells and induced senescence. While significant changes in cell cycle distributions (reduction in G1 and accumulation in G2/M) were observed upon SKF treatment, the effect was small upon 3 days of simulated microgravity. Finally, downregulation of TRPC6 was shown under simulated microgravity.

Conclusions: Simulated microgravity and TRPC channel inhibition both led to reduced proliferation and increased senescence. Furthermore, simulated microgravity reduced TRPC6 expression. IVD cell senescence and mechanotransduction may hence potentially be regulated by TRPC6 expression. This study thus reveals promising targets for future studies. These slides can be retrieved under Electronic Supplementary Material.

Keywords: Gene expression; Intervertebral disc; Mechanotransduction; Senescence; Simulated microgravity; TRP channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Cellular Senescence / drug effects
  • Humans
  • Imidazoles / pharmacology
  • Intervertebral Disc* / cytology
  • Intervertebral Disc* / metabolism
  • Mechanotransduction, Cellular / drug effects
  • TRPC6 Cation Channel* / antagonists & inhibitors
  • TRPC6 Cation Channel* / metabolism
  • TRPC6 Cation Channel* / physiology

Substances

  • Imidazoles
  • TRPC6 Cation Channel
  • TRPC6 protein, human
  • 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole